King of Prussia, Pennsylvania-based Trice Medical, which is focused on improving orthopedic diagnostics, has appointed Mark Foster as its chief commercialization officer and vice president of worldwide sales. Previously, Foster worked at Smith & Nephew. Trice Medical is backed by HealthQuest Capital, Safeguard Scientifics and BioStar Ventures.
KING OF PRUSSIA, Pa., July 7, 2016 /PRNewswire/ — Trice Medical today announced the appointment of Mark Foster as chief commercialization officer and vice president, worldwide sales. In this newly created role, Foster will lead the company’s product commercialization and sales worldwide, working closely with the product development, operations, sales and marketing teams to solidify Trice Medical’s position as a leader in the orthopedic industry while identifying and executing upon the company’s growth and strategic opportunities. Foster joins Trice Medical’s executive team and reports directly to the company’s CEO, Jeff O’Donnell, Sr.
“Mark is a consummate leader and a solid addition to our team,” said O’Donnell. “He has an impressive track record, a deep understanding of the orthopedic and global markets, and a vision for how Trice and its products will transform them. I am proud and excited that Mark has joined us to lead the next phase of both our company’s and this industry’s evolution.”
Foster comes to Trice Medical after eight years with Smith & Nephew, a global medical technology company; his last position with Smith & Nephew was Vice President, U.S. Sports Medicine in the Advanced Surgical Device Division. Earlier in his career, Foster spent eight years with Boston Scientific as a regional manager, and a director of operations and training. He started his healthcare career with Smith Kline Beecham. He holds a B.A. from the University of Richmond.
“Trice Medical is at the forefront of a revolution in camera-enabled needle technology and has a unique opportunity to bring value to patients, physicians and payers,” said Foster. “Trice Medical’s keen vision and the team’s impressive execution are reshaping this industry. The opportunity to participate directly became an irresistible draw, and I couldn’t be more excited to help Trice Medical in this next phase of growth.”
About Trice Medical
Trice Medical was founded to fundamentally improve orthopedic diagnostics for the patient, physician, and payor by providing instant, eyes-on, answers. Trice Medical has pioneered fully integrated camera-enabled technology, the mi-eye+, that provides a clinical solution optimized for the physician’s office. Trice Medical’s mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system. Trice Medical is a venture capital backed company; Safeguard Scientifics (NYSE: SFE), BioStar Ventures and HealthQuest Capital are its major investors; smaller firms and angel investors have completed the rounds. For more information, visit www.tricemedical.com; follow us on Twitter, LinkedIn and Facebook or call 610-989-8080.